Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-093810
Filing Date
2015-03-16
Accepted
2015-03-16 16:34:20
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d855921d10k.htm 10-K 1959839
2 EX-21.1 d855921dex211.htm EX-21.1 5775
3 EX-23.1 d855921dex231.htm EX-23.1 2723
4 EX-23.2 d855921dex232.htm EX-23.2 2712
5 EX-23.3 d855921dex233.htm EX-23.3 2562
6 EX-31.1 d855921dex311.htm EX-31.1 9665
7 EX-31.2 d855921dex312.htm EX-31.2 9728
8 EX-32.1 d855921dex321.htm EX-32.1 4606
  Complete submission text file 0001193125-15-093810.txt   15139461

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT sgnt-20141231.xml EX-101.INS 2429772
10 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20141231.xsd EX-101.SCH 93540
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20141231_cal.xml EX-101.CAL 145030
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20141231_def.xml EX-101.DEF 642207
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20141231_lab.xml EX-101.LAB 790152
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20141231_pre.xml EX-101.PRE 760674
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-35144 | Film No.: 15703363
SIC: 2834 Pharmaceutical Preparations